| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |